MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.
about
Activator protein 1 promotes gemcitabine‑induced apoptosis in pancreatic cancer by upregulating its downstream target BimDown-regulation of miR-497 is associated with poor prognosis in renal cancer.miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathwaysmir-329 restricts tumor growth by targeting grb2 in pancreatic cancer.MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolaseMiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection.Roles of miR-497 and its potential signaling pathway in diseases and with vascular endothelial growth factor.MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cellsTumor angiogenesis revisited: Regulators and clinical implications.Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma developmentmicroRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A.Chemoresistance in pancreatic cancer: Emerging conceptsmiR-497 expression, function and clinical application in cancer.Prognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literature.MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer.The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysismiR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression
P2860
Q28468378-24175D9B-6504-4F88-AE9E-1FDBD5915E9BQ35145299-D406AC29-5C4A-458D-8587-73339673F01CQ35739550-E01F053B-91E4-4D24-80BE-C5723573B95AQ35781438-92931AB1-C4A9-4008-AC35-D5BD1D187FBBQ36169165-060514A2-ED51-4619-8514-3688B9CB99E4Q36413483-02B212B0-A27D-4DA2-8E82-3FCB25680B86Q36557358-3325FE09-B767-4498-939B-E02EBBCF5515Q36766747-CD0D2104-841E-4AC6-AFC6-FA7D39E524AEQ36771905-237FF03C-66F8-4757-8349-22E595D7E3E4Q36772022-FBA83B30-C24A-4EFD-AE74-0C95B947CC99Q37225311-FA5C2332-F9F6-448E-97CE-932BA67C0E85Q37447951-E0C91D21-22BB-4A23-A411-7D26EC4DBD63Q37588270-DE7634D6-7027-41C1-B308-6F48F288FBAEQ37741183-1E360AB3-0D9F-4CBD-B3C9-94A4FBD13A41Q38264695-62978B53-CE40-461D-9537-C90C04D07B1EQ38755956-B30F5C9C-A3F4-4DF9-8B99-4333C0CED91AQ38795589-CDC1B11F-8718-4332-B2D2-CA29555378F2Q39393740-5C9E3177-EC44-4B1F-91F6-4F14403FBE9AQ41471395-8281091C-6B86-4584-807B-CE3CA8C063A1Q41899216-36588C2C-6DBB-449E-A627-FA3D393D56BEQ42002078-774FEAC0-1478-4BAA-9089-069EF4125537Q42317497-63990077-F5DC-4A68-9846-1AE073B08CE4Q42700661-CD267449-3877-4E9F-B251-7A4CE5B5C18DQ46791320-5E7D9BCC-6877-4623-8611-AEB79129417BQ50129161-00807B15-3E03-4A3D-9C2A-A569FE8B5A6DQ50252299-A30C1EFC-DA6F-47F6-BFC1-C669B0876D2CQ52649732-F09E6DCC-2CB1-479E-8726-7650E22B82E0Q53093295-B885E258-E348-4D39-AAEE-ABC45FCD1C44Q57116698-D2F0733F-70BF-4DB6-B2AE-CFFBF058C2D1Q58790313-ED32B0DB-F378-4E1B-96B0-B56E88BA9B11
P2860
MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@ast
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@en
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@nl
type
label
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@ast
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@en
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@nl
prefLabel
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@ast
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@en
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@nl
P2093
P2860
P356
P1433
P1476
MiR-497 downregulation contrib ...... ociates with a poor prognosis.
@en
P2093
Jianwei Xu
Shanglong Liu
Taiping Zhang
Tianxiao Wang
Wenjing Liu
Yupei Zhao
P2860
P304
P356
10.18632/ONCOTARGET.2184
P407
P577
2014-08-01T00:00:00Z